Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Davis

Showing results (181-190 of 205) with videos related to

Pageof 21
Sort By:
Archives of Neurology|December 17, 2003
Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trialCraig W Ritchie, Ashley I Bush, Andrew Mackinnon, et al.
The American Journal of Cardiology|November 11, 2008
Relation between aspirin dose, all-cause mortality, and bleeding in patients with recent cerebrovascular or coronary ischemic events (from the BRAVO Trial)Herbert D Aronow, Robert M Califf, Robert A Harrington, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|January 19, 2023
Tenecteplase versus alteplase for stroke thrombolysis evaluation (TASTE): A multicentre, prospective, randomized, open-label, blinded-endpoint, controlled phase III non-inferiority trial protocolAndrew Bivard, Carlos Garcia-Esperon, Leonid Churilov, et al.
Circulation|July 23, 2003
Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular diseaseEric J Topol, Donald Easton, Robert A Harrington, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 11, 2026
Effect of tranexamic acid for acute spontaneous intracerebral haemorrhage: a systematic review and individual patient data meta-analysisChaamanti Sivakumar Menon, Zhe Kang Law, Lisa Jane Woodhouse, et al.
Ejhaem|May 23, 2022
Fibrin clot characteristics and anticoagulant response in a SARS-CoV-2-infected endothelial modelConor McCafferty, Leo Lee, Tengyi Cai, et al.
Neuroepidemiology|October 28, 2015
Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 StudyValery L Feigin, Rita V Krishnamurthi, Priya Parmar, et al.
Lancet (London, England)|August 10, 2014
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trialsJonathan Emberson, Kennedy R Lees, Patrick Lyden, et al.
The Lancet. Neurology|June 13, 2016
Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysisWilliam N Whiteley, Jonathan Emberson, Kennedy R Lees, et al.
JAMA|October 21, 2004
Comparison of MRI and CT for detection of acute intracerebral hemorrhageChelsea S Kidwell, Julio A Chalela, Jeffrey L Saver, et al.
Pageof 21

Showing results (181-190 of 205) with videos related to

Sort By:
Pageof 21
Archives of Neurology|December 17, 2003
Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trialCraig W Ritchie, Ashley I Bush, Andrew Mackinnon, et al.
The American Journal of Cardiology|November 11, 2008
Relation between aspirin dose, all-cause mortality, and bleeding in patients with recent cerebrovascular or coronary ischemic events (from the BRAVO Trial)Herbert D Aronow, Robert M Califf, Robert A Harrington, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|January 19, 2023
Tenecteplase versus alteplase for stroke thrombolysis evaluation (TASTE): A multicentre, prospective, randomized, open-label, blinded-endpoint, controlled phase III non-inferiority trial protocolAndrew Bivard, Carlos Garcia-Esperon, Leonid Churilov, et al.
Circulation|July 23, 2003
Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular diseaseEric J Topol, Donald Easton, Robert A Harrington, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 11, 2026
Effect of tranexamic acid for acute spontaneous intracerebral haemorrhage: a systematic review and individual patient data meta-analysisChaamanti Sivakumar Menon, Zhe Kang Law, Lisa Jane Woodhouse, et al.
Ejhaem|May 23, 2022
Fibrin clot characteristics and anticoagulant response in a SARS-CoV-2-infected endothelial modelConor McCafferty, Leo Lee, Tengyi Cai, et al.
Neuroepidemiology|October 28, 2015
Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 StudyValery L Feigin, Rita V Krishnamurthi, Priya Parmar, et al.
Lancet (London, England)|August 10, 2014
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trialsJonathan Emberson, Kennedy R Lees, Patrick Lyden, et al.
The Lancet. Neurology|June 13, 2016
Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysisWilliam N Whiteley, Jonathan Emberson, Kennedy R Lees, et al.
JAMA|October 21, 2004
Comparison of MRI and CT for detection of acute intracerebral hemorrhageChelsea S Kidwell, Julio A Chalela, Jeffrey L Saver, et al.
Pageof 21